All lobbying filings

TARPLIN, DOWNS & YOUNG, LLC

Lobbying for NOVARTIS · Use innovative science and technology to discover & develop breakthrough treatments

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Apr 20, 2025

Official filing document

Lobbying activity 3

Budget/Appropriations

Federal budget issues

Health Issues

MINI Act, IRA, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies

Medicare/Medicaid

bio pharmaceutical reimbursement issues, IRA

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.